Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Tracleer online pharmacy?Did you ever feel dizzy during lipitor's first week?Who owns the patent on azelastine?What's the status of new olaparib patents in the us?Colesevelam price increase?
See the DrugPatentWatch profile for stiripentol
Stiripentol (Diacomit) is approved for use with clobazam and valproate in patients aged 2 years and older with Dravet syndrome whose seizures are not adequately controlled with these drugs alone.1 Patients weighing 30 kg or more - 50 mg/kg/day, given orally in 2 or 3 divided doses. Patients weighing less than 30 kg - 50 mg/kg/day, given orally in 2 or 3 divided doses.1
Take with food to improve absorption and reduce side effects like nausea. Powder form must be mixed with water and taken immediately; capsules can be opened and mixed with applesauce if swallowing is difficult.1
Take as soon as remembered unless close to the next dose. Do not double up.1
Not approved or recommended for children under 2 years. No approvals for other epilepsy types outside Dravet syndrome with the specified regimen.1
Higher doses increase risks of sedation, decreased appetite, and weight loss. Monitor weight and consider dose reduction if needed.1
Other Questions About Stiripentol :